INSIGHTS ON CLINICAL TRIAL DESIGN
-
Designing Successful Cell And Gene Therapy Trials
Designing cell and gene therapy trials requires specialized strategies to navigate unique complexities, ensuring successful and compliant development.
-
Why Team Integration Makes Or Breaks Marketing Applications
True team integration transcends basic collaboration, requiring the dismantling of barriers between sponsors and vendors, eliminating departmental silos, and cultivating mutual accountability.
-
How State-Of-The-Art Clinical Trial Mobile Vision Clinics Work
Are you seeking a non-traditional option to complete the eye exams necessary for your ocular clinical trials? A mobile clinic may be the solution you're looking for.
-
Practical Approaches To Clinical Trial Diversity
Gain insights on FDA diversity action plans, and the important role that data points play in ensuring inclusion of underrepresented populations.
-
Ensuring A Diverse Patient Population In Clinical Trials12/13/2024
In 2025, the FDA will require pharmaceutical companies to include diversity action plans (DAPs) for Phase II and pivotal studies.
-
Vendor Selection Bias: Why Structured Decisions Often Fail12/22/2025
Learn how subtle influences derail decisions and discover proven safeguards that promote transparency, accountability, and shared ownership for better trial outcomes.
-
How Humans And AI Collaborate To Improve Quality, Speed, And Agility In Study Build6/22/2026
Learn how combining human expertise with AI can improve speed, consistency, and oversight while identifying issues earlier and supporting higher-quality clinical trial execution.
-
From Chaos To Clarity: A Founder's View From 30 Years In Drug Development7/16/2026
Same workflows, higher stakes. A 30-year drug development veteran reveals how outdated sample handling puts trial outcomes at risk and what sponsors can do about it.
-
Leading Recruitment With A Strong Alzheimer's Referral Pool2/24/2026
A strong referral network helped the Gainesville site rapidly recruit pTau217‑positive Alzheimer’s participants while upholding high data quality, boosting enrollment and outperforming other sites.
CLINICAL TRIAL DESIGN SOLUTIONS
-
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
-
Dedicated Patient Liaison support helps coordinate participant travel, reimbursements, and visit logistics so sites stay focused and study requests keep moving forward.
-
Streamline post-approval research by embedding studies into routine clinical care. Reduce site burden and capture high-quality data for label expansion and regulatory needs.
-
With over 40 clinical trials conducted in the area of ophthalmology, Altasciences combines depth of knowledge and expert capabilities to offer you a full range of early ophthalmic clinical development.
-
Strategic planning, data-driven decisions, and global coordination accelerate clinical timelines while ensuring quality. Explore risk-based monitoring and practical ways to overcome complexity.